Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |